Drugs / Esomezol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not applicable1 trial | ||||||
| — | NCT03436914 | Sep 2018 → Oct 2019 | gastroesophageal reflux disease | Yonsei University | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| — | NCT03633097 Comparator | Nov 2018 → Dec 2020 | — | Gachon University Gil Oriental Medical Hospital | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Esomezol | “patients after surgery receive usual care alone(Cnoxane Injection 40mg, Esomezol Capsule, Synerjet Semi Tablet and Ocoron Tablet)” NCT03633097 ↗1“After the diagnosis of NERD through patient's symptom and endoscopy, PPI (esomezol) will be given for 8 weeks.” NCT03436914 ↗ |